Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Redcare Pharmacy NV banner

Redcare Pharmacy NV
XETRA:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
XETRA:RDC
Watchlist
Price: 52.35 EUR -4.64% Market Closed
Market Cap: €1.1B
Write Note Create Alert Ask AI

Wall St Price Targets

RDC Price Targets Summary
Redcare Pharmacy NV

Wall Street analysts forecast RDC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RDC is 95.63 EUR with a low forecast of 55.55 EUR and a high forecast of 147 EUR.

RDC Lowest Forecast
Wall Street Target
€55.55
6% Upside
RDC Average Forecast
Wall Street Target
€95.63
83% Upside
RDC Highest Forecast
Wall Street Target
€147
181% Upside
Lowest Forecast
Price Target
55.55 EUR
6% Upside
Average Forecast
Price Target
95.63 EUR
83% Upside
Highest Forecast
Price Target
147 EUR
181% Upside
Redcare Pharmacy NV Competitors:
Price Targets
TB
Triboo SpA
23% Upside
G
2697
Guangdong True Health Medical Technology Development Co Ltd
47% Upside
TB
Triboo SpA
23% Upside
G
2697
Guangdong True Health Medical Technology Development Co Ltd
47% Upside

Revenue
Forecast

37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 5 years is 14%.

What are analyst estimates?

Gross Profit
Forecast

38% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
38% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 38%. The projected CAGR for the next 3 years is 12%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

What are analyst estimates?

Continue RDC Research

Summary
RDC intrinsic value, competitors valuation, and company profile.
DCF Valuation
RDC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RDC stock valuation using valuation multiples.
Wall St Estimates
RDC price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RDC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Redcare Pharmacy NV listings:
F • EUR
RDC
 F • EUR
SAE1
 DUS • EUR
RDC
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RDC's stock price target?
Price Target
95.63 EUR

According to Wall Street analysts, the average 1-year price target for RDC is 95.63 EUR with a low forecast of 55.55 EUR and a high forecast of 147 EUR.

What is the Revenue forecast for Redcare Pharmacy NV?
Projected CAGR
14%

Over the last 9 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 5 years is 14%.

What is the Gross Profit forecast for Redcare Pharmacy NV?
Projected CAGR
12%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 38%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett